Shenzhen - Delayed Quote CNY

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)

22.02 -1.61 (-6.81%)

At close: October 30 at 3:04:57 PM GMT+8

Chart Range Bar

Loading chart for 002317.SZ

Previous Close 23.63
Open 23.84
Bid 22.01 x --
Ask 22.02 x --
Day's Range 21.99 - 24.20
52 Week Range 16.60 - 34.27
Volume 34,500,194
Avg. Volume 29,782,149
Market Cap (intraday) 18.715B
Beta (5Y Monthly) 0.63
PE Ratio (TTM) 91.75
EPS (TTM) 0.24
Earnings Date --
Forward Dividend & Yield 0.20 (0.85%)
Ex-Dividend Date May 29, 2026
1y Target Est 35.00

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine fumarate oral solutions; sucralfate oral suspension; reba pat film; and Azalastine Hydrochloride, Praprofen, Diquafosol Sodium, and Cyclosporine eye drops. It also focuses on the fields of respiratory antiviral, ophthalmology, cardiovascular and cerebrovascular endocrinology, anti-infection, digestion, and anti-allergy. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Dongguan, China.

www.zspcl.com

1,757

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002317.SZ

17.04%

SSE Composite Index (000001.SS)

9.32%

1-Year Return

002317.SZ

26.51%

SSE Composite Index (000001.SS)

9.73%

3-Year Return

002317.SZ

24.96%

SSE Composite Index (000001.SS)

19.11%

5-Year Return

002317.SZ

178.60%

SSE Composite Index (000001.SS)

1.46%

Earnings Per Share

No Earnings Per Share available for this ticker

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY24

Revenue 723.24M

Earnings --

Profit Margin 0.00%

FY19

FY23

FY24

200M

400M

600M

0.0%

Analyst Price Targets

35.00

35.00 Average

22.02 Current

35.00 High

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

8.96%
Return on Assets (ttm)

2.45%
Return on Equity (ttm)

4.64%
Revenue (ttm)

2.22B
Net Income Avi to Common (ttm)

199.28M
Diluted EPS (ttm)

0.24

Balance Sheet and Cash Flow

Total Cash (mrq)

1.52B
Total Debt/Equity (mrq)

3.03%
Levered Free Cash Flow (ttm)

264.09M

002424.SZ Guizhou Bailing Group Pharmaceutical Co., Ltd.

4.4500 -0.22%

002262.SZ Jiangsu Nhwa Pharmaceutical Co., LTD

21.61 +1.93%

002422.SZ Sichuan Kelun Pharmaceutical Co., Ltd.

40.15 -2.78%

002294.SZ Shenzhen Salubris Pharmaceuticals Co., Ltd.

29.89 -1.19%

002332.SZ Zhejiang Xianju Pharmaceutical Co., Ltd.

8.89 +0.34%

U.S. markets closed

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)

-15.21%

-8.36%

19.74%

16.02%

25.40%

161.52%

130.44%

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch